Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Promote Your Event
Submission Forms
Place an Ad
Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Items For Sale
Jobs
Pets
Auctions, Estate & Garage Sales
Place an ad
Services
Community
Personals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biofrontera Inc
(NQ:
BFRI
)
0.8801
-0.0089 (-1.00%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biofrontera Inc
Biofrontera Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk
January 09, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2022
January 09, 2023
Via
ACCESSWIRE
Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor Conference
November 30, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022
November 28, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk
November 21, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update
November 14, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022
November 10, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AG
November 08, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AG
October 31, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
Biofrontera Inc. Names Fred Leffler as Chief Financial Officer
October 24, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
Biofrontera Inc. to Present at the LD Micro Main Event XV Investor Conference
October 20, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
Biofrontera Inc. to Sponsor the 2022 Fall Clinical Dermatology Conference
October 18, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
Biofrontera Inc. Adopts Limited Duration Shareholder Rights Plan
October 14, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON FRIDAY OCTOBER 14, AND TUESDAY OCTOBER 18, 2022
October 12, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022
October 05, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand
October 04, 2022
Palm Beach, FL – October 4, 2022 – FinancialNewsMedia.com News Commentary – The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the...
Via
FinancialNewsMedia
Topics
Death
Economy
Exposures
Death
Economy
Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference
September 29, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement
July 27, 2022
From
Biofrontera Inc.
Via
Globe NewsWire
NASDAQ Companies Including: Biofrontera (NASDAQ:BFRI), Avalon GloboCare Corp. (NASDAQ:AVCO)
December 16, 2021
Via
Get News
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Economy
InvestorNewsBreaks – Biofrontera Inc. (NASDAQ: BFRI) Closes $18M IPO
November 29, 2021
Via
Investor Brand Network
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.